Originalbeitrag in Fachzeitschrift
A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo
Chan JF-W, Oh YJ, Yuan S, Chu H, Yeung M-L, Canena D, et al. A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo. Cell reports. Medicine [Internet]. 2022;3:100774. doi:10.1016/j.xcrm.2022.100774
api.elsevier.comAltmetric
BOKU Autor*innen
Miriam Klausberger
Dipl.-Ing. Miriam Klausberger Ph.D.
Johannes Stadlmann
Ass.Prof. Dipl.-Ing. Dr. Johannes Stadlmann
Chris Oostenbrink
Univ.Prof. Dr. Chris Oostenbrink
